Bavarian Nordic — Juni 2021
-
"Ugens Vindere & Tabere: De amerikanske life science aktier, både health care og biotech, giver nu et krystalklart købssignal, efter flere måneders stilstand i biotekindeks.
Det har også smittet meget positivt af på de danske life science aktier, blandt andet ALK-Abelló, Zealand Pharma, Genmab og Novo Nordisk".
-
Aktier/tendens: Udsigt til grøn åbning med Vestas, Ørsted og Bavarian i fokus
-
Swung-smukt:)
-
Jeg synes Bava bliver presset ned igen - shortere på spil?
-
We are very excited to catch up with the folks from Beta Bionics! Their fully automated bionic pancreas is called the iLet. They are getting closer to submitting to the US FDA and were able to give us an update on some of the most anticipated features.
(Diabetes Connections)
47 minutters podcast omkring hvordan iLet fra Beta Bionics kommer til at virke i praksis.
-
"Kate Farnsworth used open source code to create a system that tracks her diabetic daughter's blood sugar levels."
Lidt anderledes indfaldsvinkel til et job hos Beta Bionics.
-
Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific Sessions.
-
ZP: Ikke fordi jeg nødvendigvis tror det får større impact i dag, men efter minmening gar de den bedste analytiker på sagen: Nordea opj target på ZP til 280(63) fastholder Køb
-
280(263)
Ja jeg synes da også det siver noget, ku' vi snart få en nyhed tak (og ikke prostvac om igen, nej nej det holder jeg ikke til...anti-jinxHello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind